1-11 of 11
Authors: Junji Yonese
Sort by
Journal Article
Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?
Takashi Soyano and others
Japanese Journal of Clinical Oncology, Volume 53, Issue 6, June 2023, Pages 514–521, https://doi.org/10.1093/jjco/hyad019
Published: 21 March 2023
Journal Article
Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study
Motohiro Fujiwara and others
Japanese Journal of Clinical Oncology, Volume 53, Issue 3, March 2023, Pages 263–269, https://doi.org/10.1093/jjco/hyac190
Published: 15 December 2022
Journal Article
Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study
Kazuma Sasamura and others
Japanese Journal of Clinical Oncology, Volume 52, Issue 2, February 2022, Pages 170–178, https://doi.org/10.1093/jjco/hyab167
Published: 23 October 2021
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study
Get access
Yoshihiko Tomita and others
Japanese Journal of Clinical Oncology, Volume 49, Issue 6, June 2019, Pages 506–514, https://doi.org/10.1093/jjco/hyz026
Published: 22 February 2019
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study
Yoshihiko Tomita and others
Japanese Journal of Clinical Oncology, Volume 47, Issue 7, July 2017, Pages 639–646, https://doi.org/10.1093/jjco/hyx049
Published: 13 April 2017
Journal Article
Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F] fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate pancer: multicenter Phase IIb clinical trial
Hiroyoshi Suzuki and others
Japanese Journal of Clinical Oncology, Volume 47, Issue 3, March 2017, Page 283, https://doi.org/10.1093/jjco/hyw177
Published: 05 December 2016
Journal Article
Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial
Get access
Hiroyoshi Suzuki and others
Japanese Journal of Clinical Oncology, Volume 46, Issue 2, February 2016, Pages 152–162, https://doi.org/10.1093/jjco/hyv181
Published: 04 January 2016
Journal Article
Successful Use of Endoscopic Argon Plasma Coagulation for Hemorrhagic Radiation Cystitis: A Case Report
Get access
Sho Suzuki and others
Japanese Journal of Clinical Oncology, Volume 44, Issue 7, July 2014, Pages 692–695, https://doi.org/10.1093/jjco/hyu066
Published: 16 May 2014
Journal Article
Long-term Oncological Outcome and Risk Stratification in Men with High-risk Prostate Cancer Treated with Radical Prostatectomy
Get access
Shinya Yamamoto and others
Japanese Journal of Clinical Oncology, Volume 42, Issue 6, June 2012, Pages 541–547, https://doi.org/10.1093/jjco/hys043
Published: 28 March 2012
Journal Article
Risk Stratification of High-grade Prostate Cancer Treated with Antegrade Radical Prostatectomy with Intended Wide Resection
Get access
Shinya Yamamoto and others
Japanese Journal of Clinical Oncology, Volume 39, Issue 6, June 2009, Pages 387–393, https://doi.org/10.1093/jjco/hyp032
Published: 24 April 2009
Journal Article
Antegrade Radical Retropubic Prostatectomy with Preliminary Ligation of Vascular Pedicles in 614 Consecutive Patients
Get access
Satoru Kawakami and others
Japanese Journal of Clinical Oncology, Volume 37, Issue 7, July 2007, Pages 528–533, https://doi.org/10.1093/jjco/hym051
Published: 01 July 2007
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals